Physician profile
Lawrence O Baum
NPI 1336375484
$32,592.00
in general payments reported to CMS, 2019-2025
67 companies · $10K in 2025
The $10K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $3,498 · 2020: $1,686 · 2021: $2,632 · 2022: $5,369 · 2023: $4,274 · 2024: $5,026 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Long Term Medical Supply Or Device Loan: $5,143 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,183.63 |
| Long Term Medical Supply Or Device Loan | $5,142.85 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,227.27 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700, Spaceoar System |
| Hmu Consumables, LLC | $5,142.85 | 2025 | Dornier Medtech |
| Coloplast Corp | $3,077.51 | 2019-2025 | Altis |
| Medtronic, INC. | $2,226.00 | 2021-2025 | Interstim |
| Myriad Genetic Laboratories, INC. | $1,249.63 | 2020-2025 | Prolaris, Bracanalysis Cdx |
| Endo Pharmaceuticals INC. | $1,125.12 | 2019-2023 | Aveed, Xiaflex |
| Janssen Biotech, INC. | $1,098.78 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Pfizer INC. | $867.64 | 2019-2025 | |
| Angiodynamics, INC. | $852.68 | 2023-2025 | Nanoknife, Solero, Biosentry Tract Sealant System |
| Biotissue Holdings INC. | $798.46 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $797.54 | 2023-2025 | Gemtesa, Orgovyx, Myfembree |
| Astellas Pharma US INC | $746.68 | 2019-2025 | Xtandi, Padcev, Myrbetriq |
| Antares Pharma, INC. | $606.91 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Axonics, INC. | $570.78 | 2020-2024 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $561.55 | 2019-2025 |
Show all 67 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $487.33 | 2019-2025 | Botox |
| Dendreon Pharmaceuticals LLC | $480.24 | 2019-2025 | Provenge |
| Ferring Pharmaceuticals INC. | $469.78 | 2019-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $407.93 | 2022-2025 | Pylarify |
| Procept Biorobotics Corporation | $391.24 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Medtronic USA, INC. | $372.41 | 2019 | |
| Urogen Pharma, INC. | $349.56 | 2023-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $347.60 | 2020-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Terumo Medical Corporation | $331.08 | 2021-2022 | |
| Healthtronics Stone Solutions, LLC | $316.54 | 2024-2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Neotract INC. | $268.79 | 2019-2020 | |
| Abc Home Medical Supply, INC. | $199.15 | 2022-2025 | |
| Teleflex LLC | $198.93 | 2019-2024 | Urolift |
| Allergan, INC. | $189.96 | 2019-2022 | |
| Tolmar, INC. | $183.84 | 2023-2025 | Jatenzo, Eligard |
| Astrazeneca Pharmaceuticals LP | $169.82 | 2021-2023 | Lynparza |
| Endo USA, INC. | $152.60 | 2024-2025 | Xiaflex, Aveed |
| Olympus America INC. | $146.49 | 2023 | Itind System |
| Tolmar Pharmaceuticals, INC. | $141.79 | 2019-2022 | |
| Aytu Biopharma, INC. | $138.09 | 2019 | |
| Convatec INC. | $125.66 | 2022-2023 | |
| Telix Pharmaceuticals | $121.22 | 2023-2025 | Illuccix |
| 180 Medical, INC. | $115.90 | 2023-2025 | Gentlecath |
| Acerus Pharmaceuticals Corporation | $103.39 | 2020-2022 | |
| Janssen Scientific Affairs, LLC | $103.35 | 2022 | |
| Tempus Ai, INC | $100.00 | 2024 | |
| Accord Healthcare, INC. | $96.08 | 2023-2025 | |
| Myovant Sciences INC. | $94.70 | 2022 | |
| Amgen INC. | $90.39 | 2019-2020 | |
| Urovant Sciences INC | $89.48 | 2022 | |
| Ambu INC. | $82.28 | 2021-2025 | |
| Verity Pharmaceuticals INC. | $76.25 | 2023-2024 | Trelstar |
| C. R. Bard, INC. & Subsidiaries | $68.79 | 2023-2025 | Aptra, Bard Urinary Drainage Bag |
| Travere Therapeutics, INC. | $66.49 | 2019-2021 | |
| Immunitybio, INC. | $62.27 | 2025 | |
| Halozyme INC | $60.17 | 2023 | |
| Azurity Pharmaceuticals, INC. | $55.19 | 2025 | Azmiro |
| Zyla Life Sciences, INC. | $53.17 | 2019 | |
| Novartis Pharmaceuticals Corporation | $51.31 | 2025 | |
| Hollister Incorporated | $44.37 | 2023 | Vapro Pocket |
| Blue Earth Diagnostics | $43.22 | 2022-2024 | |
| Novo Nordisk INC | $30.39 | 2024 | Sogroya |
| Baxter Healthcare | $25.38 | 2023 | Tisseel |
| Rochester Medical Corporation | $22.28 | 2022 | |
| Steris Corporation | $19.13 | 2024 | |
| Avanos Medical | $19.00 | 2023 | On-Q* Pump and Accessories |
| Alnylam Pharmaceuticals INC. | $16.04 | 2023 | Oxlumo |
| Therapeuticsmd, INC. | $15.28 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.26 | 2022 | |
| Clarus Therapeutics INC. | $13.74 | 2021 | |
| Laborie Medical Technologies Corp. | $11.87 | 2022 | |
| Kerecis Limited | $8.38 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$69,355.82 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$14,814.84 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Baum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.